A share price of LifeStance Health Group Inc [LFST] is currently trading at $6.06, up 10.38%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The LFST shares have gain 3.77% over the last week, with a monthly amount drifted -7.20%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
LifeStance Health Group Inc [NASDAQ: LFST] stock has seen the most recent analyst activity on May 27, 2025, when UBS upgraded its rating to a Buy but kept the price target unchanged to $8.50 for it. Previously, KeyBanc Capital Markets started tracking the stock with Overweight rating on April 08, 2025, and set its price target to $9. On April 03, 2025, Canaccord Genuity initiated with a Buy rating and assigned a price target of $8 on the stock. Goldman upgraded its rating to a Buy but stick to its price target of $10 on December 16, 2024. Barclays initiated its recommendation with a Underweight and recommended $7 as its price target on January 03, 2024. TD Cowen downgraded its rating to Market Perform for this stock on May 15, 2023, and upped its price target to $9. In a note dated January 06, 2023, Morgan Stanley upgraded an Overweight rating on this stock but restated the target price of $8.
LifeStance Health Group Inc experienced fluctuations in its stock price throughout the past year between $4.64 and $8.61. LifeStance Health Group Inc [NASDAQ: LFST] shares were valued at $6.06 at the most recent close of the market.
Analyzing the LFST fundamentals
Trailing Twelve Months sales for LifeStance Health Group Inc [NASDAQ:LFST] were 1.28B which represents 10.83% growth. Gross Profit Margin for this corporation currently stands at 0.3% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at -0.03%, and Net Profit Margin reading is -0.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.02 and Total Capital is -0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.80 points at the first support level, and at 5.53 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.22, and for the 2nd resistance point, it is at 6.37.
Ratios To Look Out For
To put it in perspective, the Current Ratio for LifeStance Health Group Inc [NASDAQ:LFST] is 1.47. Also, the Quick Ratio is 1.47, while the Cash Ratio stands at 0.65. Considering the valuation of this stock, the price to sales ratio is 1.84, the price to book ratio is 1.62.
Transactions by insiders
Recent insider trading involved Bessler Robert, Director, that happened on Apr 09 ’25 when 4900.0 shares were sold. Director, Bessler Robert completed a deal on Apr 08 ’25 to sell 14.0 shares. Meanwhile, Director Bessler Robert bought 4900.0 shares on Apr 09 ’25.
